$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
利妥昔单抗联合伊布替尼的治疗效果
2025-10-19 11:44:20
Check Details
利妥昔单抗+伊布替尼可显著延长慢性淋巴细胞白血病无进展生存期
2025-10-19 11:44:20
Check Details
慢性淋巴细胞白血病新疗法:利妥昔单抗+伊布替尼
2025-10-19 11:44:20
Check Details
白血病患者注射利妥昔单抗需要了解的事项
2025-10-19 11:44:20
Check Details
利妥昔单抗可延长慢性淋巴细胞白血病患者生存期
2025-10-19 11:44:20
Check Details
利妥昔单抗用于慢性淋巴细胞白血病的疗效
2025-10-19 11:44:20
Check Details
FDA批准利妥昔单抗联合伊布替尼治疗慢性淋巴细胞白血病
2025-10-19 11:44:20
Check Details
利妥昔单抗治疗慢性淋巴细胞白血病的安全性及有效性
2025-10-19 11:44:20
Check Details
吉妥单抗治疗急性髓性白血病的效果怎么样?
2025-10-19 11:44:20
Check Details
吉妥单抗可用于儿童急性髓性白血病的治疗
2025-10-19 11:44:20
Check Details
吉妥单抗能减少儿童急性髓系白血病的复发且改善其无进展生存期
2025-10-19 11:44:20
Check Details
阿卡替尼对慢性淋巴细胞白血病的疗效
2025-10-19 11:44:20
Check Details
1
2
...
596
597
598
599
600
601
602
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
2
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
3
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
4
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
5
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
6
A Key Therapeutic Breakthrough Against T315I-Mutant CML
7
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
8
Tafasitamab and Lenalidomide Combination Therapy Guide
9
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
10
Gilteritinib Professional Medication Guide & Dosage Management
11
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
12
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia